New Imaging Workstation Provides Superior Sensitivity for Gel/Blot Analyses
|
By LabMedica International staff writers Posted on 08 Jan 2013 |

Image: The PXi Multiapplication gel and blot imaging system (Photo courtesy of Syngene).
A new high resolution, multiapplication imaging system includes a wide range of lighting options, a new-generation camera, and specialized software, enabling exceptional sensitivity for analysis of gels and blots.
The PXi gel and blot imaging system from Syngene (Frederick, MD, USA) is a sophisticated and easy-to-use, compact workstation for the capture and image analysis of chemiluminescent and fluorescent blots, fluorescent and IR gels, visible gels and blots, and even 2D gels. PXi is available in three versions - with a 4, 6, or 8 million pixel high performance camera and suitable lens that results in the system having superior sensitivity such that even faint gels, chemiluminescence blots, and faint fluorescent bands can be imaged. In addition, the cameras are cooled to enable longer exposures, which can be a necessity for chemiluminescence and for some fluorescence applications.
The high performance range of PXi has been designed to provide a high level of control and to excel at a wide range of applications. The system has options for advanced automation or manual control. A number of lighting options can be utilized including plug and play LED modules for Red, Green, Blue and IR light. These novel lighting systems provides the user with the ability to perform colored fluorescent, multiplex, and colorimetric imaging. The new UltraSlim blue LED transilluminator provides a solution for imaging “safe dyes.” An integral 7-position filter wheel can accommodate a wide range of Syngene filters. PXi is controlled by the GeneSys acquisition and capture software. Using its database, GeneSys can automatically configure PXi to capture any type of image.
Related Links:
Syngene
The PXi gel and blot imaging system from Syngene (Frederick, MD, USA) is a sophisticated and easy-to-use, compact workstation for the capture and image analysis of chemiluminescent and fluorescent blots, fluorescent and IR gels, visible gels and blots, and even 2D gels. PXi is available in three versions - with a 4, 6, or 8 million pixel high performance camera and suitable lens that results in the system having superior sensitivity such that even faint gels, chemiluminescence blots, and faint fluorescent bands can be imaged. In addition, the cameras are cooled to enable longer exposures, which can be a necessity for chemiluminescence and for some fluorescence applications.
The high performance range of PXi has been designed to provide a high level of control and to excel at a wide range of applications. The system has options for advanced automation or manual control. A number of lighting options can be utilized including plug and play LED modules for Red, Green, Blue and IR light. These novel lighting systems provides the user with the ability to perform colored fluorescent, multiplex, and colorimetric imaging. The new UltraSlim blue LED transilluminator provides a solution for imaging “safe dyes.” An integral 7-position filter wheel can accommodate a wide range of Syngene filters. PXi is controlled by the GeneSys acquisition and capture software. Using its database, GeneSys can automatically configure PXi to capture any type of image.
Related Links:
Syngene
Latest BioResearch News
- Study Identifies Distinct Immune Signatures to Early Depression and Psychosis
- Genetic Mutation Behind Aggressive Adult Leukemia Offers Treatment Clues
- Disease Gene Discovery Advances Diagnosis of Rare Movement Disorders
- Genetic Discovery Could Improve Diagnosis of Drug-Resistant Epilepsy
- Genetic Discovery May Improve Diagnosis of Rare Dementia Subtype
- Mass Spectrometry Technique Detects Protein and Sugar Changes in Neurodegeneration
- Barcoded DNA Sheds Light on Hidden Complexities in Breast Cancer Detection
- CRISPR-Based Platform Pinpoints Drivers of Acute Myeloid Leukemia in Patient Cells
- Protective Brain Protein Emerges as Biomarker Target in Alzheimer’s Disease
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
Channels
Clinical Chemistry
view channel
Blood-Based Screening Test Targets Early Detection of Colorectal Cancer
Colorectal cancer (CRC) is a leading cause of cancer-related death worldwide, with more than 60% of cases still diagnosed at a late stage. Uptake of existing screening tools remains suboptimal,... Read more
Automated NfL Assay Supports Monitoring of Neurological Disorders
Neuroaxonal injury occurs across a wide range of neurological disorders and remains difficult to monitor noninvasively over time. Blood-based measurement of neurofilament light chain (NfL) provides a biologically... Read moreMolecular Diagnostics
view channel
New Respiratory Panel Expands Pathogen Detection to 25 Targets
Respiratory infections often present with overlapping symptoms, complicating differential diagnosis in acute and community settings. The stakes are higher for older adults, young children, and people with... Read more
Simple Nasal Swab May Reveal Early Signs of Alzheimer’s Disease
Alzheimer’s disease affects millions worldwide but remains difficult to detect at its earliest, pre-symptomatic stage. Clinicians need tools that can identify biological changes before cognitive symptoms... Read moreHematology
view channel
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read moreImmunology
view channel
Study Identifies Inflammatory Pathway Driving Immunotherapy Resistance in Bladder Cancer
Bladder cancer remains a prevalent malignancy with variable responses to immune checkpoint inhibitors. Clinicians often observe elevated C-reactive protein and interleukin-6 in affected patients, yet the... Read more
Microfluidic Chip Detects Cancer Recurrence from Immune Response Signals
Early identification of treatment response and relapse remains a major challenge in solid tumors, where minimal residual disease is difficult to detect with routine imaging and blood tests.... Read moreMicrobiology
view channel
Breath Analysis Approach Offers Rapid Detection of Bacterial Infection
Accurate and rapid identification of bacterial infections remains challenging in acute care, where delays can hinder timely, targeted therapy. Infectious diseases are a major cause of mortality worldwide,... Read more
Study Highlights Accuracy Gaps in Consumer Gut Microbiome Kits
Direct-to-consumer gut microbiome kits promise personalized insights by profiling fecal bacteria and generating health readouts, but their analytical accuracy remains uncertain. A new study shows that... Read more
WHO Recommends Near POC Tests, Tongue Swabs and Sputum Pooling for TB Diagnosis
Tuberculosis (TB) remains one of the world’s leading infectious disease killers, yet millions of cases go undiagnosed or are detected too late. Barriers such as reliance on sputum samples, limited laboratory... Read morePathology
view channel
Biopsy-Based Gene Test Predicts Recurrence Risk in Lung Adenocarcinoma
Lung cancer is the leading cause of cancer death, killing more people in the United States than breast, prostate, and colon cancers combined. In lung adenocarcinoma (LUAD), tumors that invade nearby blood... Read more
AI-Powered Tool to Transform Dermatopathology Workflow
Skin cancer accounts for the largest number of cancer diagnoses in the United States, placing sustained pressure on pathology services. Diagnostic interpretation can be variable for challenging melanocytic... Read moreTechnology
view channel
Online Tool Supports Family Screening for Inherited Cancer Risk
Genetic test results in oncology often have implications for relatives who may share inherited cancer risk. Many health systems lack structured processes to help patients alert family members, limiting... Read more
Portable Breath Sensor Detects Pneumonia Biomarkers in Minutes
Pneumonia is commonly confirmed with chest X-rays or laboratory assays that can take hours, delaying clinical decisions in acute and outpatient settings. Breath-based diagnostics promise faster answers... Read moreIndustry
view channel
Integrated DNA Technologies Expands into Clinical Diagnostics
Integrated DNA Technologies (IDT; Coralville, Iowa, USA) has announced the launch of Archer FUSIONPlex-HT Dx and VARIANTPlex-HT Dx. This launch marks the company’s first in vitro diagnostic (IVD) offerings... Read more




.jpg)



